Alkermes, Avadel Pharmaceuticals file US merger paperwork
MLex Summary: Alkermes and Avadel Pharmaceuticals have filed paperwork with the US antitrust authorities for their $2.1 billion transaction, according to a filing with the US Securities and Exchange Commission. The waiting...To view the full article, register now.
Already a subscriber? Click here to view full article